Luisa Fernanda Briones-Márquez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Luisa Fernanda Briones-Márquez has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Edgar Jose Lopez-Naranjo
Project Engineering Department, University Center of Exact Sciences and Engineering (CUCEI), University of Guadalajara, Guadalajara 44430, Jalisco, Mexico
3 shared publications - Luis Javier González-Ortiz
Chemistry Department, CUCEI, University of Guadalajara
2 shared publications Azucena Herrera-González
CUCEI-Universidad de Guadalajara, 44430, Guadalajara, Jal, Mexico
1 shared publication- Azucena Herrera-González
Departamento de Ingeniería Química, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Jalisco, Mexico
1 shared publication - César A. Dueñas-Bolaños
CUCEI-Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara C.P. 44430, JAL, Mexico
1 shared publication David Uribe-Rodríguez
Centro de biotecnología SANTER S.C., 45040, Guadalajara, Jal, Mexico
1 shared publication
Latest Publications
- Open Access
Polydeoxyribonucleotide (PDRN) from Diverse Biological Sources: Comparative Biochemistry, Biotechnological Production, and Translational Potential
Polydeoxyribonucleotide (PDRN) has emerged as a promising bioactive biomaterial with broad applications in regenerative medicine because of its anti-inflammatory, angiogenic, and tissue-repair properties. Traditionally obtained from salmonid sperm DNA, it has been reported to promote tissue regeneration primarily by activating adenosine A2A receptors and the nucleotide salvage pathway, thereby stimulating fibroblast proliferation, extracellular matrix remodeling, collagen synthesis, and angiogenesis. This review provides a comprehensive overview of the biochemical characteristics, mechanisms of action, extraction methods, and translational potential of PDRN from different biological sources. In addition to conventional animal-derived PDRN, recent advances have introduced plant-derived (PhytoPDRN) and microbial- or algae-derived alternatives, offering improved sustainability, scalability, and reduced environmental impact. Preliminary in vitro evidence suggests that these emerging sources may exhibit regenerative and antioxidant activities; however, differences in molecular characteristics, experimental models, and study designs currently preclude establishing biological or clinical equivalence with salmon-derived PDRN. Finally, the translational perspectives, industrial challenges, and future research directions are analyzed, highlighting the need for standardized manufacturing processes, comparative clinical trials, and sustainable production strategies. Overall, PDRN is a DNA-derived biomaterial of growing interest in regenerative medicine and cosmetic applications. At the same time, novel biological sources may contribute to the development of more sustainable and clinically effective next-generation PDRN-based therapies.
Open AccessPolydeoxyribonucleotide (PDRN) from Diverse Biological Sources: Comparative Biochemistry, Biotechnological Production, and Translational Potential
Polydeoxyribonucleotide (PDRN) has emerged as a promising bioactive biomaterial with broad applications in regenerative medicine because of its anti-inflammatory, angiogenic, and tissue-repair properties. Traditionally obtained from salmonid sperm DNA, it has been reported to promote tissue regeneration primarily by activating adenosine A2A receptors and the nucleotide salvage pathway, thereby stimulating fibroblast proliferation, extracellular matrix remodeling, collagen synthesis, and angiogenesis. This review provides a comprehensive overview of the biochemical characteristics, mechanisms of action, extraction methods, and translational potential of PDRN from different biological sources. In addition to conventional animal-derived PDRN, recent advances have introduced plant-derived (PhytoPDRN) and microbial- or algae-derived alternatives, offering improved sustainability, scalability, and reduced environmental impact. Preliminary in vitro evidence suggests that these emerging sources may exhibit regenerative and antioxidant activities; however, differences in molecular characteristics, experimental models, and study designs currently preclude establishing biological or clinical equivalence with salmon-derived PDRN. Finally, the translational perspectives, industrial challenges, and future research directions are analyzed, highlighting the need for standardized manufacturing processes, comparative clinical trials, and sustainable production strategies. Overall, PDRN is a DNA-derived biomaterial of growing interest in regenerative medicine and cosmetic applications. At the same time, novel biological sources may contribute to the development of more sustainable and clinically effective next-generation PDRN-based therapies.
- Open Access
Biosynthesis of Silver Nanoparticles Using Tagetes erecta: Extract Characterization, Morphological Modification Using Structure Directing or Heterogeneous Nucleating Agents, and Antibacterial Evaluation
This work reports the biosynthesis of silver nanoparticles (AgNPs) using an autoclave method with Tagetes erecta extract (TEE) as a source of reducing agents, silver nitrate (AgNO3) as the metal precursor, and a nucleating agent (i.e., sodium chloride [S]) or a structure director agent (i.e., gum Arabic [G] or hydrous magnesium silicate/talc powder [T]) to tailor the morphology of AgNPs. Since the properties and potential applications of AgNPs depend on their size and shape, these additives were employed to achieve morphological control. Phytochemical screening tests and UPCL-Qtof-MS/MS profiling of TEE were performed to identify the compounds present in the extract, indicating that highly polar phenolic compounds such as saponins, tannins, and flavonoids are present in TEE, allowing it to act as a source of reducing/stabilizing agents. The biosynthesized AgNPs exhibited different morphologies (i.e., spheres, rods, ribbons, and wires) depending on the modifying agent used (i.e., S, G, or T). Characterization techniques including scanning electron microscopy (SEM), transmission electron microscopy (TEM), ultraviolet–visible spectroscopy (UV–vis), and X-ray diffraction (XRD) confirmed the successful use of S, G, and T in modulating AgNP morphology. The results of the antibacterial activity evaluation demonstrated that both TEE and AgNPs possess bacteriostatic activity against Escherichia coli and Enterococcus faecalis, with the use of S as a nucleating agent increasing the inhibitory effect of AgNPs.
Open AccessBiosynthesis of Silver Nanoparticles Using Tagetes erecta: Extract Characterization, Morphological Modification Using Structure Directing or Heterogeneous Nucleating Agents, and Antibacterial Evaluation
This work reports the biosynthesis of silver nanoparticles (AgNPs) using an autoclave method with Tagetes erecta extract (TEE) as a source of reducing agents, silver nitrate (AgNO3) as the metal precursor, and a nucleating agent (i.e., sodium chloride [S]) or a structure director agent (i.e., gum Arabic [G] or hydrous magnesium silicate/talc powder [T]) to tailor the morphology of AgNPs. Since the properties and potential applications of AgNPs depend on their size and shape, these additives were employed to achieve morphological control. Phytochemical screening tests and UPCL-Qtof-MS/MS profiling of TEE were performed to identify the compounds present in the extract, indicating that highly polar phenolic compounds such as saponins, tannins, and flavonoids are present in TEE, allowing it to act as a source of reducing/stabilizing agents. The biosynthesized AgNPs exhibited different morphologies (i.e., spheres, rods, ribbons, and wires) depending on the modifying agent used (i.e., S, G, or T). Characterization techniques including scanning electron microscopy (SEM), transmission electron microscopy (TEM), ultraviolet–visible spectroscopy (UV–vis), and X-ray diffraction (XRD) confirmed the successful use of S, G, and T in modulating AgNP morphology. The results of the antibacterial activity evaluation demonstrated that both TEE and AgNPs possess bacteriostatic activity against Escherichia coli and Enterococcus faecalis, with the use of S as a nucleating agent increasing the inhibitory effect of AgNPs.
- Open Access
Semicontinuous Microemulsion Polymerization of Polymeric Nanoparticles of Poly(cyanoacrylates) and Poly(caprolactone)
Polymeric nanoparticles based on poly(ethyl cyanoacrylate) (PECA) and poly(ε-caprolactone) (PCL) were synthesized via semicontinuous microemulsion polymerization for potential biomedical applications. A systematic evaluation of four surfactants (Tween 80, Alkonat L70, Genapol LRO, and Brij-20) was carried out to determine their effects on micelle formation and particle size. Brij-20 enabled the formation of nanoparticles under 100 nm, with optimal conditions identified at 4% surfactant concentration and pH 1.75. The polymerization process included acid-catalyzed ring-opening of ε-caprolactone, followed by the semicontinuous addition of ethyl-2-cyanoacrylate under an inert atmosphere. Copolymerization was confirmed through FT-IR spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and differential scanning calorimetry, revealing a glass transition temperature (Tg) of 110.9 °C, indicating PECA as the dominant phase. Thermogravimetric analysis showed two decomposition events corresponding to each polymer. Transmission electron microscope analysis revealed nanoparticles averaging 51.74 nm in diameter. These findings demonstrate the feasibility of producing PECA-PCL nanoparticles with controlled size and composition, suitable for drug delivery and other biomedical uses.
Open AccessSemicontinuous Microemulsion Polymerization of Polymeric Nanoparticles of Poly(cyanoacrylates) and Poly(caprolactone)
Polymeric nanoparticles based on poly(ethyl cyanoacrylate) (PECA) and poly(ε-caprolactone) (PCL) were synthesized via semicontinuous microemulsion polymerization for potential biomedical applications. A systematic evaluation of four surfactants (Tween 80, Alkonat L70, Genapol LRO, and Brij-20) was carried out to determine their effects on micelle formation and particle size. Brij-20 enabled the formation of nanoparticles under 100 nm, with optimal conditions identified at 4% surfactant concentration and pH 1.75. The polymerization process included acid-catalyzed ring-opening of ε-caprolactone, followed by the semicontinuous addition of ethyl-2-cyanoacrylate under an inert atmosphere. Copolymerization was confirmed through FT-IR spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, and differential scanning calorimetry, revealing a glass transition temperature (Tg) of 110.9 °C, indicating PECA as the dominant phase. Thermogravimetric analysis showed two decomposition events corresponding to each polymer. Transmission electron microscope analysis revealed nanoparticles averaging 51.74 nm in diameter. These findings demonstrate the feasibility of producing PECA-PCL nanoparticles with controlled size and composition, suitable for drug delivery and other biomedical uses.